Semorinemab
Product Specifications
CAS Number
2159141-27-0
Target
Microtubule Associated
Related Pathways
Cytoskeletal Signaling
Purity
0.972
Bioactivity
Semorinemab (RG6100) is a humanised monoclonal antibody targeting the N-terminal domain of tau protein with a Kd of 3.8 nM, suitable for Alzheimer's disease research. It binds all six human tau isoforms and reduces tau accumulation.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1258831-01 0.02 mg (E-Coli)
Recombinant Shewanella putrefaciens Probable septum site-determining protein MinC (minC)
Sign In for Pricing
View Details MBS1258831-02 0.1 mg (E-Coli)
Recombinant Shewanella putrefaciens Probable septum site-determining protein MinC (minC)
Sign In for Pricing
View Details MBS1258831-03 0.02 mg (Yeast)
Recombinant Shewanella putrefaciens Probable septum site-determining protein MinC (minC)
Sign In for Pricing
View Details MBS1258831-04 0.1 mg (Yeast)
Recombinant Shewanella putrefaciens Probable septum site-determining protein MinC (minC)
Sign In for Pricing
View Details